Home › Funds › Dodge & Cox › GILD
Dodge & Cox position in GILD
GILEAD SCIENCES INC · Health Care
Dodge & Cox reported holding 21,800,593 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.25B, representing 1.74% of its reported portfolio and ranking #17 among its reported holdings. Dodge & Cox has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Dodge & Cox's GILD position evolved
Dodge & Cox first disclosed a stake in GILD in Q3 2021 at 37,266,692 shares (US$2.60B). The position peaked in Q1 2025 at 32,694,791 shares, worth US$3.66B. Across 21 filings, Dodge & Cox increased the stake 0 time(s), trimmed it 13 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 21,800,593 shares valued at US$3.25B — a reduction of -1,876,974 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 37.27M | $2.60B | New |
| Q4 2021 | 37.17M | $2.70B | Hold |
| Q1 2022 | 37.03M | $2.20B | Hold |
| Q2 2022 | 36.97M | $2.28B | Hold |
| Q3 2022 | 36.37M | $2.24B | Reduce |
| Q4 2022 | 35.89M | $3.08B | Reduce |
| Q1 2023 | 34.70M | $2.88B | Reduce |
| Q2 2023 | 33.98M | $2.62B | Reduce |
| Q3 2023 | 33.53M | $2.51B | Reduce |
| Q4 2023 | 33.30M | $2.70B | Reduce |
| Q1 2024 | 33.17M | $2.43B | Hold |
| Q2 2024 | 33.12M | $2.27B | Hold |
| Q3 2024 | 33.05M | $2.77B | Hold |
| Q4 2024 | 32.95M | $3.04B | Hold |
| Q1 2025 | 32.69M | $3.66B | Reduce |
| Q2 2025 | 30.82M | $3.42B | Reduce |
| Q3 2025 | 30.13M | $3.34B | Reduce |
| Q4 2025 | 26.28M | $3.23B | Reduce |
| Q1 2026 | 24.25M | $3.38B | Reduce |
| Q2 2026 | 23.68M | $2.99B | Reduce |
| Q3 2026 | 21.80M | $3.25B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- BlackRock Inc 125.25M sh · $18.67B · Q3 2026
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 27.66M sh · $4.12B · Q3 2026
- T. Rowe Price Associates 27.66M sh · $4.12B · Q3 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- DODGE & COX 21.80M sh · $3.25B · Q3 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
More on Dodge & Cox
FAQ
How long has Dodge & Cox held GILD?
Dodge & Cox has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Dodge & Cox's current position in GILD?
As of Q3 2026, Dodge & Cox holds 21.80M shares of GILD (GILEAD SCIENCES INC), valued at $3.25B, representing 1.74% of its reported portfolio and ranking #17.
Has Dodge & Cox been buying or selling GILD?
In the latest 13F filing (Q3 2026), Dodge & Cox reduced its position in GILD. The position peaked in Q1 2025 at 32.69M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.